Discovering Genetic Variants in Hypertrophic Cardiomyopathy With Multiple Machine Learning Techniques

Insights

Machine learning identified key genetic variants influencing hypertrophic cardiomyopathy (HCM). This approach reveals complex gene interactions, aiding in understanding disease modulation and discovering potential pathogenic variants.

Area of Science:

  • Genetics
  • Computational Biology
  • Cardiology

Background:

  • Hypertrophic cardiomyopathy (HCM) has significant genetic underpinnings.
  • Understanding the complex interplay of genetic variants that modify HCM phenotype is crucial.
  • High-dimensional genetic data presents challenges for traditional analysis.

Purpose of the Study:

  • To analyze genetic variants in hypertrophic cardiomyopathy patients using diverse machine learning techniques.
  • To identify relevant variants and understand their interactions.
  • To discover potential disease modulators and pathogenic variants.

Main Methods:

  • Statistical univariate analysis with p-value adjustment.
  • Linear classifiers (SVM, FDA) for feature weighting.
  • Informative variable identification and Bayesian networks for inter-variant relationships.
  • Manifold learning for latent space representation.
  • Linkage disequilibrium and frequency tables for variant association analysis.

Main Results:

  • Ten genetic variants were consistently identified as significant across multiple methods.
  • Twenty-two variants were significant in at least three out of five applied methods.
  • Machine learning successfully detected disease-associated variants, including specific pathogenic founder variants.

Conclusions:

  • Machine learning provides a robust framework for analyzing complex genetic data in hypertrophic cardiomyopathy.
  • This methodology can identify significant disease-associated variants and potential genetic modulators.
  • The findings contribute to a deeper understanding of the genetic architecture of HCM.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
48
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
14.2K
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
53